Confirmatory spirometry for adults hospitalized with a diagnosis of asthma or chronic obstructive pulmonary disease exacerbation

BMC Pulmonary Medicine

Jerry A Krishnan²  Valerie G Press³  Min J Joo⁴  Jeffrey Charbeneau⁴  Carlos A Camargo Jr¹  Edward T Naureckas³  Frank Huang³  Valentin Prieto Centurion⁴ 

[1] Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA;University of Illinois Hospital & Health Sciences System, Medical Center Administration Building, 914 S. Wood Street, MC 973, Chicago, IL, 60612, USA;University of Chicago Medicine, Chicago, IL, USA;University of Illinios at Chicago, Chicago, IL, USA

关键词: Quality improvement;    Spirometry;    Hospitalization;    Exacerbation;    COPD;    Asthma;   

Others  :  1136303
DOI  :  10.1186/1471-2466-12-73

 received in 2012-07-17, accepted in 2012-11-29,  发布年份 2012

【 摘 要 】

Background

Objective measurement of airflow obstruction by spirometry is an essential part of the diagnosis of asthma or COPD. During exacerbations, the feasibility and utility of spirometry to confirm the diagnosis of asthma or chronic obstructive pulmonary disease (COPD) are unclear. Addressing these gaps in knowledge may help define the need for confirmatory testing in clinical care and quality improvement efforts. This study was designed to determine the feasibility of spirometry and to determine its utility to confirm the diagnosis in patients hospitalized with a physician diagnosis of asthma or COPD exacerbation.

Methods

Multi-center study of four academic healthcare institutions. Spirometry was performed in 113 adults admitted to general medicine wards with a physician diagnosis of asthma or COPD exacerbation. Two board-certified pulmonologists evaluated the spirometry tracings to determine the proportion of patients able to produce adequate quality spirometry data. Findings were interpreted to evaluate the utility of spirometry to confirm the presence of obstructive lung disease, according to the 2005 European Respiratory Society/American Thoracic Society recommendations.

Results

There was an almost perfect agreement for acceptability (κ = 0.92) and reproducibility (κ =0.93) of spirometry tracings. Three-quarters (73%) of the tests were interpreted by both pulmonologists as being of adequate quality. Of these adequate quality tests, 22% did not present objective evidence of obstructive lung disease. Obese patients (BMI ≥30 kg/m²) were more likely to produce spirometry tracings with no evidence of obstructive lung disease, compared to non-obese patients (33% vs. 8%, p = 0.007).

Conclusions

Adequate quality spirometry can be obtained in most hospitalized adults with a physician diagnosis of asthma or COPD exacerbation. Confirmatory spirometry could be a useful tool to help reduce overdiagnosis of obstructive lung disease, especially among obese patients.

【 授权许可】

   
2012 Centurion et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Mushlin A, Black E, Connolly C, Buonaccorso K, Eberly S: The necessary length of hospital stay for chronic pulmonary disease. JAMA 1991, 266(1):80-83.
• [2]Krishnan V, Diette GB, Rand CS, Bilderback AL, Merriman B, Hansel NN, Krishnan JA: Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Crit Care Med 2006, 174(6):633-638.
• [3]National Institutes of Health. National Heart: Lung and Blood Institute: NHLBI Fact Book, Fiscal Year 2011. http://www.nhlbi.nih.gov/about/factbook/chapter4.htm webcite
• [4]Moorman J, Rudd R, Johnson C, King M, Minor P, Bailey C, Scalia M, Akinbami L: National Surveillance for Asthma --- United States, 1980--2004. MMWR 2007, 56(SS08):1-14-18-54.
• [5]Jencks SF, Williams MV, Coleman EA: Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009, 360(14):1418-1428.
• [6]Steer J, Norman EM, Afolabi OA, Gibson GJ, Bourke SC: Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Thorax 2012, 67(2):117-121.
• [7]Watson L, Turk F, James P, Holgate ST: Factors associated with mortality after an asthma admission: a national United Kingdom database analysis. Respir Med 2007, 101(8):1659-1664.
• [8]Pozo-Rodriguez F, Lopez-Campos JL, Alvarez-Martinez CJ, Castro-Acosta A, Aguero R, Hueto J, Hernandez-Hernandez J, Barron M, Abraira V, Forte A, Sanchez Nieto JM, Lopez-Gabaldon E, Cosio BG, Agusti A, AUDIPOC Study Group: Clinical audit of COPD patients requiring hospital admissions in Spain: AUDIPOC study. PLoS One 2012, 7(7):e42156.
• [9]Patil SP, Krishnan JA, Lechtzin N, Diette GB: In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med 2003, 163(10):1180-1186.
• [10]Lindenauer P, Pekow P, Gao S, Crawford A, Gutierrez B, Benjamin E: Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 2006, 144(12):894-903.
• [11]Mularski R, Asch S, Shrank W: The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest 2006, 130(6):1844-1850.
• [12]Stein B, Bautista A, Schumock G, Lee T, Charbeneau J, Lauderdale D, Naureckas E, Meltzer D, Krishnan J: The validity of ICD-9-CM diagnosis codes for identifying patients hospitalized for COPD exacerbations. Chest 2012, 141(1):87-93.
• [13]Rea H, Kenealy T, Adair J, Robinson E, Sheridan N: Spirometry for patients in hospital and one month after admission with an acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis 2011, 6:527-532.
• [14]Mahajan A, Diette G, Hatipoglu U, Bilberback A, Ridge A, Harris V: V D, Badlani S, Lewis S, Charbeneau J, Naureckas E, Krishnan J: High frequency chest wall oscillation for asthma and chronic obstructive pulmonary disease exacerbations: a randomized sham-controlled clinical trial. Respir Res 2011, 12(1):120. BioMed Central Full Text
• [15]Press V, Arora V, Shah L, Lewis S, Ivy K, Charbeneau J, Badlani S, Naureckas E, Mazurek A, Krishnan J: Misuse of Respiratory Inhalers in Hospitalized Patients with Asthma or COPD. J Gen Intern Med 2011, 26(635–642):635.
• [16]Miller M, Hankinson J: V B, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, Van der Grinten C, Gustafsson P, Jensen R, Johnson D, MacIntyre N, McKay R, Navajas D, Pedersen O, Pellegrino R, Viegi G, Wanger J: Standardisation of spirometry. Eur Respir J 2005, 26(2):319-338.
• [17]Pellegrino R, Viegi G: V B, Crapo R, Burgos F, Casaburi R, Coates A, van der Grinten C, Gustafsson P, Hankinson J, Jensen R, Johnson D, MacIntyre N, McKay R, Miller M, Navajas D, Pedersen O, Wanger J: Interpretative strategies for lung function tests. Eur Respir J 2005, 26(5):948-68.
• [18]Hankinson J, Odencrantz J, Fedan K: Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999, 159(1):179-187.
• [19]Landis R, Koch G: The measurement of observer agreement for categorical data. Biometrics 1977, 33(1):159-174.
• [20]WHO: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series 894; 2000.
• [21]Joo M, Au D, Fitzgibbon M, McKell J, Lee T: Determinants of Spirometry Use and Accuracy of COPD Diagnosis in Primary Care. J Gen Intern Med 2011, 26(11):1272-1277.
• [22]Walters JA, Walters EH, Nelson M, Robinson A, Scott J, Turner P, Wood-Baker R: Factors associated with misdiagnosis of COPD in primary care. Prim Care Respir J 2011, 20(4):396-402.
• [23]Zwar NA, Marks GB, Hermiz O, Middleton S, Comino EJ, Hasan I, Vagholkar S, Wilson SF: Predictors of accuracy of diagnosis of chronic obstructive pulmonary disease in general practice. Med J Aust 2011, 195(4):168-171.
• [24]Aaron S, Vandemheen K, Boulet L, McIvor R, Fitzgerald J, Hernandez P, Lemiere C, Sharma S, Field S, Alvarez G, Dales R, Doucette S, Fergusson D: Overdiagnosis of asthma in obese and nonobese adults. CMAJ 2008, 179(11):1121-1131.
• [25]Scott S, Currie J, Albert P, Calverley P, Wilding J: Risk of Misdiagnosis, Health-Related Quality of Life, and BMI in Patients Who Are Overweight With Doctor-Diagnosed Asthma. Chest 2012, 141(3):616-624.
• [26]Mannino D, Etzel R, Flanders W: Do the medical history and physical examination predict low lung function? Arch Intern Med 1993, 153(16):1892-1897.
• [27]Willman Silk A, McTigue K: Reexamining the Physical Examination for Obese Patients. JAMA 2011, 305(16):1656-1657.
• [28]Newman K, Mason U, Schmaling K: Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med 1995, 152(4):1382-1386.